Schedule 13G ownership disclosure
SORRENTO THERAPEUTICS IN
Security class unavailable · CUSIP: 83587F202
Event date: 2019-02-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 460,588
- Percent of class
- 0.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-007632
- Form type
- SC 13G
- Filer
- Ally Bridge Group Capital Partners II, L.P.
- CIK
- CIK 1609313
- Filed
- Feb 13, 2019
- Reporting period
- Feb 13, 2019
- Description
- Schedule 13G beneficial ownership